articleCancer ResearchDec 14, 2010HYBRID OA

A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients

SRStéphanie RoesslerHJHu-Liang JiaABAnuradha BudhuMFMarshonna ForguesQYQing-Hai Ye

National Institutes of Health · Chinese Academy of Medical Sciences & Peking Union Medical College · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Metastasis-related recurrence often occurs in hepatocellular carcinoma (HCC) patients who receive curative therapies. At present, it is challenging to identify patients with high risk of recurrence, which would warrant additional therapies. In this study, we sought to analyze a recently developed metastasis-related gene signature for its utility in predicting HCC survival, using 2 independent cohorts consisting of a total of 386 patients who received radical resection. Cohort 1 contained 247 predominantly HBV-positive cases analyzed with an Affymetrix platform, whereas cohort 2 contained 139 cases with mixed etiology analyzed with the NCI Oligo Set microarray platform. We employed a survival risk prediction…

Citation impact

1,091
total citations
FWCI
6.81
Percentile
100%
References
48
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Medicine
  • Hepatocellular carcinoma
  • Gene signature
  • Oncology
  • Internal medicine
  • Metastasis
  • Cohort
  • Stage (stratigraphy)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding